Susquehanna International Group
NSPRZ

Susquehanna International Group’s InspireMD, Inc. Series B Warrants NSPRZ Stock Holding History

Susquehanna International Group’s Portfolio NSPRZ Stock Details NSPRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-244,335
Closed -$10K – 13585
2021
Q1 		$10K Sell
244,335
-283,199
-54% -$13.4K ﹤0.01% 12158
2020
Q4 		$7K Sell
527,534
-126,531
-19% -$1.62K ﹤0.01% 10926
2020
Q3 		$7K Buy
654,065
+169,871
+35% +$2.34K ﹤0.01% 10438
2020
Q2 		$8K Sell
484,194
-25,610
-5% -$256 ﹤0.01% 9993
2020
Q1 		$4K Buy
509,804
+59,692
+13% +$472 ﹤0.01% 10122
2019
Q4 		$1K Sell
450,112
-11,900
-3% -$95 ﹤0.01% 9597
2019
Q3 		$5K Sell
462,012
-10,600
-2% -$98 ﹤0.01% 10051
2019
Q2 		$6K Buy
+472,612
New +$2.17K ﹤0.01% 10103
2018
Q3 		– Sell
-19,054
Closed – – 10581
2018
Q2 		$0 Buy
19,054
+200
+1% +$4 ﹤0.01% 10715
2018
Q1 		$0 Sell
18,854
-74,894
-80% -$2.08K ﹤0.01% 10498
2017
Q4 		$2K Hold
93,748
– – ﹤0.01% 9139
2017
Q3 		$2K Hold
93,748
– – ﹤0.01% 8714
2017
Q2 		$7K Buy
+93,748
New +$12.2K ﹤0.01% 9086

Other funds holding NSPRZ

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's NSPRZ Position: Q2 2021 in Review

Susquehanna International Group sold out of InspireMD, Inc. Series B Warrants (NSPRZ) in Q2 2021, closing a stake of 244,335 shares — an estimated $10K sold.

Susquehanna International Group first reported a position in NSPRZ in Q2 2017 and held it in 13 quarters. The position peaked at $10K in Q1 2021. 2 funds tracked by Wall St. Rank hold NSPRZ as of Q2 2021.

  • Susquehanna International Group reported no remaining InspireMD, Inc. Series B Warrants position as of Q2 2021 after selling out during the quarter.
  • Susquehanna International Group sold 244,335 InspireMD, Inc. Series B Warrants shares in Q2 2021, an estimated $10K.
  • Susquehanna International Group first reported a position in InspireMD, Inc. Series B Warrants in Q2 2017 and held it in 13 quarters.
  • Susquehanna International Group's InspireMD, Inc. Series B Warrants position peaked at $10K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held InspireMD, Inc. Series B Warrants as of Q2 2021.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.